In this setting, the buzz is clearly neurologic in

origin. Comparisons with other disease states such as diabetic neuropathy do not adequately characterize the symptoms presented by these 2 cases. Diabetic neuropathy commonly presents with a broad range of positive symptoms typically described as “pins and needles” and prickling or tingling. Our patients presented with a novel complaint of vibratory sensation in the perineum. In both cases, the associated symptoms and Afatinib molecular weight physical examination findings support a diagnosis of prostatitis. “Buzzing” has been used as a descriptor in multiple other disease states with multifactorial etiologies similar to those proposed for CP/CPPS and might represent a novel description within the vast prostatitis symptomatology. It is clearly necessary

for more research to be completed as to the pathogenesis of prostatitis and its symptoms, and we hope these GW-572016 purchase data allow clinicians to better recognize and manage patients with this disorder. Moldwin R: Taris Biomedical–investigator, medical advisory board; Afferent Pharmaceuticals–investigator; Urigen Pharmaceuticals–investigator, medical advisory board. “
“Sacral neuromodulation (ie, InterStim) has been shown to be an effective treatment for a variety of bladder control issues. It was first introduced by Tanagho and Schmidt in 1981 and approved by the Food and Drug Administration for the treatment of urge incontinence in 1991. In 1999, it was approved for the treatment of urinary retention and urinary frequency.1 This

technique involves the surgical implantation of a device in the abdomen or buttock region, which is then attached to an electrode to stimulate sacral nerves.2 InterStim uses electrical impulses to modulate afferent sacral signals through found inhibition. These impulses modulate the nerves and muscles used to control the bladder.3 This reversible treatment option has been shown to be successful in existing research. Specifically, current research has shown that sacral neuromodulation can be used to successfully treat urinary urge incontinence, urgency frequency, urinary retention, and even fecal incontinence.2 Recent research focuses primarily on sacral neuromodulation in conjunction with non-neurogenic urinary tract dysfunction.1 However, a study by Wallace et al3 demonstrated the effectiveness of sacral neuromodulation on patients with underlying neurologic disease, ranging from multiple sclerosis and Parkinson disease to spina bifida and spinal cord disease. This research seems to indicate that InterStim therapy can be successful in cases of nonobstructive bladder control issues in patients with neurogenic or non-neurogenic causes. EM is a 24-year-old woman who presented with a history urinary retention brought on by stress since early premenstrual childhood. She reported multiple episodes in which she would become spontaneously unable to urinate and have painless retention.